EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fetuin-A and type II diabetes mellitus

Lamyaa Ismail Ahmed, Sabila Gomaa Mousa, Nagwa Abd El-Ghaffar Mohamed, Zeinab Ahmed Yousry, Mayada Rabea Abd-El Khalaa

The Egyptian Journal of Internal Medicine · 2014-12 · 26 (4) · 157-161

DOI: 10.4103/1110-7782.148140 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Egyptian Journal of Internal Medicine, online erschienen am 30.12.2014. Verfasst von Lamyaa Ismail Ahmed und 4 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The pathophysiology of type II DM is complex; in addition to impaired insulin secretion from Beta-cells, reduced insulin sensitivity was found to play a predominant role in the pathogenesis of the disease. Fetuin-A is a he-patic secretory protein that binds the insulin receptor and inhibits insulin action both in vivo and in vitro.

Objective

Our aim was to investigate whether serum fetuin-A levels predict the incidence of insulin resistance in type II DM. Patient and methods The present study included 40 patients who had type II diabetes mellitus served as patients group and 40 apparently normal individuals served as control group. All patient and control groups were subjected to the following: full medical history and thorough physical examination, fasting & post prandial blood glucose, urea, creatinine, lipid profile, CRP, insulin and fetuin-A.

Results

There was highly significant increase in serum insulin, serum fetuin A and HOMA-IR in diabetic group compared with control group. There was significant positive correlation between serum fetuin A and serum insulin, FBG, HbA1c and serum CRP. Also a significant positive correlation between HOMA-IR and serum fetuin A, serum insulin and HbA1c were found.

Conclusion

We concluded that fetuin-A may play a role in the pathogenesis of type II DM, and high serum fetuin-A has a strong association with IR and glycemic control in type II diabetic patients. Future studies are recommended to establish the possibility of using fetuin-A as a predictor of insulin resistance in type II diabetic patients.

Zitieren

APA

Ahmed, L. I., Mousa, S. G., Mohamed, N. A. E., Yousry, Z. A., & Khalaa, M. R. A. (2014). Fetuin-A and type II diabetes mellitus. The Egyptian Journal of Internal Medicine, 26(4), 157-161. https://doi.org/10.4103/1110-7782.148140

Vancouver

Ahmed LI, Mousa SG, Mohamed NAE, Yousry ZA, Khalaa MRA. Fetuin-A and type II diabetes mellitus. The Egyptian Journal of Internal Medicine. 2014;26(4):157-161. doi:10.4103/1110-7782.148140

BibTeX
@article{Ahmed2014,
  author = {Ahmed, Lamyaa Ismail and Mousa, Sabila Gomaa and Mohamed, Nagwa Abd El-Ghaffar and Yousry, Zeinab Ahmed and Khalaa, Mayada Rabea Abd-El},
  title = {Fetuin-A and type II diabetes mellitus},
  journal = {The Egyptian Journal of Internal Medicine},
  year = {2014},
  volume = {26},
  number = {4},
  pages = {157--161},
  doi = {10.4103/1110-7782.148140}
}
Kostenlos starten →